The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia

Biological Psychiatry

Volumn 42, Issue 8, 1997, Pages 648-654

  Marzella, Phillip L ^a   Hill, Christine ^a   Keks, Nicholas ^a   Singh, Bruce ^b   Copolov, David ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

Author keywords

Brain; Dopamine D4 like sites; Postmortem; Schizophrenia

Indexed keywords

DOPAMINE 4 RECEPTOR; EMONAPRIDE; RACLOPRIDE; TRITIUM; BENZAMIDE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DRD3 PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN; NEUROLEPTIC AGENT; SALICYLAMIDE DERIVATIVE;

ADULT; AGED; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; FEMALE; HUMAN; ISOTOPE LABELING; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA; BRAIN CORTEX; CAUDATE NUCLEUS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PUTAMEN; REFERENCE VALUE;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZAMIDES; CAUDATE NUCLEUS; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; PUTAMEN; RACLOPRIDE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; REFERENCE VALUES; SALICYLAMIDES; SCHIZOPHRENIA;

EID: 0030610932     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00471-4     Document Type: Article

References (48)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. 1987;American Psychiatric Association, Washington DC.
2. Angrist B, Sathananthan G, Wilk S, Gershon S. Amphetamine psychosis Behavioural and biochemical aspects . J Psychiatr Res. 11:1974;13-23.
3. Bell DS. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry. 111:1965;701-707.
4. Cross AJ, Crow T, Owen F. 3H-Flupenthixol binding in post-mortem brains of schizophrenics Evidence for a selective increase in dopamine D2 receptors . Psychopharmacology (Berl). 74:1981;122-124.
5. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res Rev. 19:1994;223-239.
6. Farde L, Wiesel F, Hall H, Halldin C, Stone-Elander S, Sedvall G. No D2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry. 44:1987;671-672.
7. Farde L, Wiesel F, Stone-Elander S, et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry. 47:1989;213-219.
8. 3H]sulpiride binding in rat caudate-putamen Autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals . Synapse. 2:1988;521-531.
9. Hess EJ, Bracha S, Kleinman JE, Creese I. Dopamine receptor subtype imbalance in schizophrenia. Life Sci. 40:1987;1487-1497.
10. 3H]neuroleptic binding . Eur J Pharmacol. 14:1987;4163-4171.
11. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature. 277:1979;93-96.
12. Lee T, Seeman P. Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am J Psychiatry. 137:1980;191-197.
13. Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornykeiwicz O. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature. 274:1978;897-900.
14. Mackay AVP, Bird Ed, Spokes EG, et al. Dopamine receptors and schizophrenia Drug effect or illness? Lancet. i:1980;915-916.
15. Mackay AVP, Iversen LL, Rossor M, et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry. 39:1982;991-997.
16. Malmberg A, Jackson D, Eriksson A, Mohell N. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B and D3 receptors. Mol Pharmacol. 43:1993;749-754.
17. Mansour A, Meador-Woodruff J, Burke S, et al. Differential distribution of D2 and D4 dopamine receptor mRNAs in the rat brain An in situ hybridization study . Soc Neurosci Abstr. 17:1991;599.
18. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem. 66:1996;915-919.
19. Meador-Woodruff JH, Mansour A, Work C, et al. Localisation of D4 and D5 dopamine receptor mRNAs in the human brain. Soc Neurosci Abstr. 17:1991;599.
20. Mita T, Hanada S, Nishino N, et al. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry. 21:1986;1407-1414.
21. Murray AM, Hyde TM, Knable MB, et al. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci. 15:1995;2186-2191.
22. Owen F, Cross AJ, Crow T, Longden A, Poulter M, Riley GJ. Increased dopamine-receptor sensitivity in schizophrenia. Lancet. i:1978;223-225.
23. Reynolds GP. Dopamine receptors in schizophrenia? J Neurochem. 66:1996;881-882.
24. Reynolds GP, Czudek C. Status of the dopaminergic system in post-mortem brain in schizophrenia. Psychopharmacol Bull. 3:1988;345-347.
25. Reynolds GP, Mason SL. Are striatal dopamine D4 receptors increased in schizophrenia? J Neurochem. 63:1994;1576-1577.
26. 4 receptors in drug-treated schizophrenia. Eur J Pharmacol. 281:1995;R5.
27. Reynolds GP, Reynolds LM, Riederer P, Jellinger K, Gabriel E. Dopamine receptors and schizophrenia Drug effect or illness [letter] . Lancet. ii:1980;1251.
28. 3H]raclopride binding sites in postmortem brains from schizophrenic violent suicide victims. Psychopharmacology (Berl). 109:1992;410-414.
29. Schwarcz R, Creese I, Coyle JT, Snyder SH. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature. 271:1978;766-768.
30. Seeman P. Dopamine receptor sequences Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4 . Neuropsychopharmacology. 7:1992;261-284.
31. Seeman P. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands Implications for human brain positron emission tomography . Eur J Pharmacol Mol Pharmacol. 227:1992;139-146.
32. 3H]nemonapride . J Neurochem. 64:1995;1413-1415.
33. Seeman P, Van Tol HHM. Dopamine D4 receptors in schizophrenia Reply . J Neurochem. 66:1996;882-883.
34. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:1976;717-719.
35. 3H]spiperone depend on tissue concentration Analysis and examples . J Neurochem. 43:1984;221-235.
36. Seeman P, Bzowej NH, Guan HC, et al. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology. 1:1987;5-15.
37. 3H]raclopride Implications for positron emission tomography of the human brain . Synapse. 13:1989;96-97.
38. Seeman P, Guan H, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature. 365:1993;441-445.
39. Seeman P, Guan H-C, Van Tol HHM, Niznik HB. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse. 14:1993;247-253.
40. 125I]epidepride . Eur J Pharmacol. 286:1995;R3-R5.
41. Sibley DR, Monsma FJ. Molecular biology of dopamine receptors. Trends in Pharmacol Sciences. 13:1992;61-69.
42. Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res. 681:1995;109-116.
43. Terai M, Hidaka K, Nakamura Y. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine D2 receptor binding to rat striatum. Eur J Pharmacol. 173:1989;2-3.
44. Theodorou A, Reavill C, Jenner P, Marsden CD. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D2 receptors exist postsynaptically on corticostriate afferents and striatal neurons. J Pharm Pharmacol. 33:1981;439-444.
45. Toru M, Watanabe S, Shibuya H, et al. Neurotransmitter, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand. 78:1988;121-137.
46. Van Tol HHM, Bunzow JR, Guan H, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
47. 3 dopamine receptors in a range of tissues and under different conditions. J Neurochem. 64:1995;940-943.
48. Wong DF, Wagner HN, Tune LE, et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science. 234:1986;1558-1563.